Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alena Grebe

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Atherosclerosis|April 20, 2012
IL-1, quo vadis?Alena Grebe, Eicke Latz
Current Rheumatology Reports|February 16, 2013
Cholesterol crystals and inflammationAlena Grebe, Eicke Latz
Circulation Research|January 17, 2015
Danger signaling in atherosclerosisSebastian Zimmer, Alena Grebe, Eicke Latz
Circulation Research|June 9, 2018
NLRP3 Inflammasome and the IL-1 Pathway in AtherosclerosisAlena Grebe, Florian Hoss, Eicke Latz
Biochemical and Biophysical Research Communications|July 16, 2016
Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in miceNiklas Bode, Alena Grebe, Anja Kerksiek, et al.
Plos One|May 13, 2021
Non-linear optical imaging of atherosclerotic plaques in the context of SIV and HIV infection prominently detects crystalline cholesterol estersMin Hi Park, Jeffrey L Suhalim, Firas Elmastour, et al.
International Journal of Molecular Sciences|September 26, 2015
Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout MiceSofie M A Walenbergh, Tom Houben, Tim Hendrikx, et al.
Nature Immunology|July 2, 2013
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammationFrederick J Sheedy, Alena Grebe, Katey J Rayner, et al.
Science Translational Medicine|April 8, 2016
Cyclodextrin promotes atherosclerosis regression via macrophage reprogrammingSebastian Zimmer, Alena Grebe, Siril S Bakke, et al.
Nature Immunology|December 10, 2013
High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3Dominic De Nardo, Larisa I Labzin, Hajime Kono, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Atherosclerosis|April 20, 2012
IL-1, quo vadis?Alena Grebe, Eicke Latz
Current Rheumatology Reports|February 16, 2013
Cholesterol crystals and inflammationAlena Grebe, Eicke Latz
Circulation Research|January 17, 2015
Danger signaling in atherosclerosisSebastian Zimmer, Alena Grebe, Eicke Latz
Circulation Research|June 9, 2018
NLRP3 Inflammasome and the IL-1 Pathway in AtherosclerosisAlena Grebe, Florian Hoss, Eicke Latz
Biochemical and Biophysical Research Communications|July 16, 2016
Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in miceNiklas Bode, Alena Grebe, Anja Kerksiek, et al.
Plos One|May 13, 2021
Non-linear optical imaging of atherosclerotic plaques in the context of SIV and HIV infection prominently detects crystalline cholesterol estersMin Hi Park, Jeffrey L Suhalim, Firas Elmastour, et al.
International Journal of Molecular Sciences|September 26, 2015
Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout MiceSofie M A Walenbergh, Tom Houben, Tim Hendrikx, et al.
Nature Immunology|July 2, 2013
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammationFrederick J Sheedy, Alena Grebe, Katey J Rayner, et al.
Science Translational Medicine|April 8, 2016
Cyclodextrin promotes atherosclerosis regression via macrophage reprogrammingSebastian Zimmer, Alena Grebe, Siril S Bakke, et al.
Nature Immunology|December 10, 2013
High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3Dominic De Nardo, Larisa I Labzin, Hajime Kono, et al.
Pageof 1